InterCure Ltd - Aset Bersih saben Siji Saham INCR

InterCure Ltd. relies on steady demand from chronic pain patients, which creates a stable cash flow. The key book value metric illustrates capital preservation during periods of market shifts, while 11.40 represents the latest level value. Expansion in Europe and Israel drives growth, which is further complemented by the digitalization of orders and the automation of warehouse logistics.

The assessment of investment reliability for assets is based on an analysis of net asset coverage of capital, excluding speculative premiums. This indicator, equal to 11.40, is calculated as the ratio of equity to the number of shares, reflecting the real value of the tangible resources of InterCure Ltd. involved in the distribution of pharmaceutical cannabis, which allows the degree of investment protection to be determined via the book value per share coefficient.